In 2024, the global renal anemia market is valued at approximately USD 5.4 billion and is projected to reach around USD 8.7 billion by 2032. This reflects a compound annual growth rate (CAGR) of about 6.1%. Growth is supported by the rising number of CKD patients and the development of new